Search - tctmd.com

Displaying 1 - 15 of 15

Sort: Relevancy | Date

News Daily News

FDA Grants First HF Indication for IV Iron to Ferric Carboxymaltose

Shelley Wood

June 05, 2023

News Daily News

Sotagliflozin Gets FDA Approval in HF Across EF Spectrum

Shelley Wood

May 30, 2023

News Daily News

Top Heart Failure News of 2022

Shelley Wood

January 04, 2023

News Daily News

STRONG-HF: Fast Optimal GDMT Cuts Deaths, Hospitalizations in Acute HF

Shelley Wood

October 17, 2022

News Daily News

AHA Urges More Home-Based Dialysis in Advanced Kidney Failure

Michael O'Riordan

August 18, 2022

News Daily News

Dapagliflozin Safe, Effective in Diabetes Regardless of Background CV Meds

Shelley Wood

July 25, 2022

News Daily News ESC Heart Failure 2022

SERENADE: No Benefit, Possible Harm With Macitentan in HFpEF and PAH

Shelley Wood

May 22, 2022

News Daily News

Therapeutic-Dose Heparin in COVID-19: Who Benefits, Who Doesn’t

Shelley Wood

August 04, 2021

News Daily News

Dapagliflozin US Cost-effectiveness Data Expose Barriers to HF Care

Shelley Wood

May 27, 2021

News Daily News

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

Shelley Wood

December 17, 2020

News Daily News

LEADER Analysis Reassures on Liraglutide in Diabetic Patients With Heart Failure

Shelley Wood

March 10, 2020

News Daily News

Proportionate and Disproportionate MR: A ‘Framework’ for MitraClip and Medical Therapy

Shelley Wood

May 09, 2019

News Daily News

How HF Drugs Help and Harm Female Patients: A Call for Sex-Specific Reporting

Shelley Wood

February 26, 2019

News Daily News

TCTMD’s Top 10 Most Popular Stories for January 2018

Shelley Wood

January 31, 2018

News Daily News

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

Shelley Wood

December 26, 2017

Advertisement

FDA Grants First HF Indication for IV Iron to Ferric Carboxymaltose

Sotagliflozin Gets FDA Approval in HF Across EF Spectrum

Top Heart Failure News of 2022

STRONG-HF: Fast Optimal GDMT Cuts Deaths, Hospitalizations in Acute HF

AHA Urges More Home-Based Dialysis in Advanced Kidney Failure

Dapagliflozin Safe, Effective in Diabetes Regardless of Background CV Meds

SERENADE: No Benefit, Possible Harm With Macitentan in HFpEF and PAH

Therapeutic-Dose Heparin in COVID-19: Who Benefits, Who Doesn’t

Dapagliflozin US Cost-effectiveness Data Expose Barriers to HF Care

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

LEADER Analysis Reassures on Liraglutide in Diabetic Patients With Heart Failure

Proportionate and Disproportionate MR: A ‘Framework’ for MitraClip and Medical Therapy

How HF Drugs Help and Harm Female Patients: A Call for Sex-Specific Reporting

TCTMD’s Top 10 Most Popular Stories for January 2018

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content